AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2011
Jul 12, 2011
35124_dirs_2011-07-12_8df0b9e1-a554-4b8e-a385-11d9d0c33ed5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-07-08
Reporting Person: Fritz Frederick J. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-08 | Options to Purchase Celsion Corporation Common Stock | $3.46 | A | 30000 | Acquired | 2021-07-08 | Celsion Corporation Common Stock (30000) | Direct |
Footnotes
F1: Options to purchase shares of Celsion Corporation Common Stock vest in thirds over three years, with the first vesting date on July 8, 2012 and annually thereafter.
F2: Closing price of Celsion Corporation Common Stock on date of award.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23